Main Street Financial Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-278
| Closed | -$292K | – | 534 |
|
|
2024
Q3 | $292K | Buy |
278
+4
| +1% | +$4.21K | 0.03% | 428 |
|
|
2024
Q2 | $288K | Buy |
274
+1
| +0.4% | +$1.05K | 0.03% | 439 |
|
|
2024
Q1 | $263K | Buy |
273
+6
| +2% | +$5.78K | 0.03% | 438 |
|
|
2023
Q4 | $235K | Sell |
267
-2
| -0.7% | -$1.76K | 0.03% | 412 |
|
|
2023
Q3 | $221K | Buy |
+269
| New | +$221K | 0.03% | 415 |
|
|
2023
Q2 | – | Sell |
-272
| Closed | -$223K | – | 455 |
|
|
2023
Q1 | $223K | Buy |
+272
| New | +$223K | 0.03% | 408 |
|
|
2022
Q2 | – | Sell |
-293
| Closed | -$205K | – | 482 |
|
|
2022
Q1 | $205K | Buy |
+293
| New | +$205K | 0.03% | 426 |
|
|
2021
Q2 | – | Sell |
-2,781
| Closed | -$1.32M | – | 453 |
|
|
2021
Q1 | $1.32M | Buy |
+2,781
| New | +$1.32M | 0.23% | 103 |
|